Chimerix Inc., has priced its public offering of 3.775 Million Common shares at $39.75 per share. Gross Proceeds would be of $150,056,250. Bid will be closed by June 16, and the Net proceeds will fund R&D, working capital and general corporate purposes. View the full release here.
Auris Medical Holding AG. has announced first quarter results for FY-2015. The results shows Zero Revenues and EPS was improved from -$0.32 to -$0.28 YoY. View the full earnings release here.
Nymox Pharmaceutical Corporation is a bio pharmaceutical company, has announced its Annual Financial result s for FY-2014. As per the report the firm Revenues down by 57%, EPS was -#0.13 and Quick Assets were $0.6 Million 100% up. View the full earnings release here.